Clinical trials are health-related studies in people that are closely supervised and carefully follow a pre-defined protocol. Each study answers scientific questions and tries to find better ways to prevent, screen for, diagnose or treat a disease. Clinical trials may be done to see how a new treatment compares with the standard treatment or to see if a new treatment is safe and effective for a certain condition or disease. Participation in this type of research involves treatment with an experimental treatment or medical device, which may or may not provide a direct benefit to the individual. A clinical trial must be conducted for all new treatments before the FDA will approve the treatment for the public. The Emory ALS Center is actively engaged in research projects involving clinical trials of new medications to slow the progression of ALS.
Clinical Trials Currently Enrolling
Biogen Ataxin Study: ENROLLING
This is a first-in-human gene therapy trial for sporadic ALS to evaluate the safety of BIIB-105. There will be 6 cohorts, with subjects being randomized 3:1 to receive active drug or placebo. Five doses of drug will be administered via lumbar puncture over 12 weeks, with total participation period to be approximately 29 weeks. For more information, please contact Karon Simmons via email.